Harold E. van Wart
Director/Board Member presso Idun Pharmaceuticals, Inc.
Profilo
Harold E.
van Wart currently works at Idun Pharmaceuticals, Inc., as Director.
Dr. van Wart also formerly worked at CymaBay Therapeutics, Inc., as President, Chief Executive Officer & Director from 2003 to 2017, The Bay Area Bioscience Association, as Chairman, California Biomedical Innovation Alliance, as Chairman, Biotechnology Innovation Organization, as Director, Conatus Pharmaceuticals, Inc., as Independent Director, Syntex Corp., as Vice President & Head-Therapy-Roche Bioscience from 1999 to 2000, and Florida State University, as Faculty Member from 1978 to 1992.
Dr. van Wart received his doctorate degree in 1975 from Cornell University and undergraduate degree in 1969 from State University of New York at Binghamton.
Posizioni attive di Harold E. van Wart
| Società | Posizione | Inizio |
|---|---|---|
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Director/Board Member | - |
Precedenti posizioni note di Harold E. van Wart
| Società | Posizione | Fine |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Chief Executive Officer | 29/03/2017 |
| The Bay Area Bioscience Association | Chairman | 26/12/2014 |
| Syntex Corp. | Corporate Officer/Principal | 01/01/2000 |
| Florida State University | Corporate Officer/Principal | 01/01/1992 |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Chairman | - |
Formazione di Harold E. van Wart
| Cornell University | Doctorate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
| Syntex Corp. | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
| The Bay Area Bioscience Association | Health Technology |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Health Technology |
- Borsa valori
- Insiders
- Harold E. van Wart
